Brolucizumab
Brolucizumab Shows Promise in Treating Persistent Diabetic Macular Edema
Researchers at Southern Medical University in Guangzhou, China, have conducted a study to evaluate the efficacy and safety of intravitreal brolucizumab 6 mg in Chinese subjects with persistent diabetic macular edema. The study, titled "Brolucizumab efficacy and safety single-arm descriptive trial in patients with persistent diabetic macular edema (BEST